Sanofi Share Price London S.E.

Equities

0A2V

US80105N1054

Pharmaceuticals

Market Closed - London S.E. 08:10:39 27/10/2023 pm IST 5-day change 1st Jan Change
41.75 USD -21.08% Intraday chart for Sanofi -14.36% -15.81%

Financials

Sales 2024 * 46.35B 49.76B 4,152B Sales 2025 * 49.8B 53.46B 4,460B Capitalization 115B 123B 10,285B
Net income 2024 * 7.08B 7.6B 634B Net income 2025 * 8.69B 9.33B 778B EV / Sales 2024 * 2.63 x
Net Debt 2024 * 6.99B 7.51B 626B Net Debt 2025 * 2.37B 2.54B 212B EV / Sales 2025 * 2.35 x
P/E ratio 2024 *
16.5 x
P/E ratio 2025 *
13.3 x
Employees 86,088
Yield 2024 *
4.21%
Yield 2025 *
4.43%
Free-Float 87.13%
More Fundamentals * Assessed data
Dynamic Chart
1 day-21.08%
1 week-14.36%
Current month-14.14%
1 month-14.36%
3 months-14.11%
6 months-15.81%
Current year-15.81%
More quotes
1 week
41.75
Extreme 41.7487
49.67
1 month
41.75
Extreme 41.7487
49.69
Current year
41.75
Extreme 41.7487
52.77
1 year
41.75
Extreme 41.7487
55.67
3 years
36.99
Extreme 36.988
58.00
5 years
36.99
Extreme 36.988
58.00
10 years
36.99
Extreme 36.988
58.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/19/01
Chief Operating Officer 40 01/22/01
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 70 01/14/01
Director/Board Member 62 28/20/28
Director/Board Member 64 22/20/22
More insiders
Date Price Change Volume
01/24/01 49.45 +1.69% 306
28/24/28 48.63 +1.28% 181
27/24/27 48.01 -1.51% 202
26/24/26 48.75 -1.10% 125,071
25/24/25 49.29 +1.11% 267

Delayed Quote London S.E., October 27, 2023 at 08:10 pm IST

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.85 EUR
Average target price
107.9 EUR
Spread / Average Target
+17.43%
Consensus